IRD
Opus Genetics·NASDAQ
--
--(--)
--
--(--)
IRD fundamentals
Opus Genetics (IRD) released its earnings on Aug 13, 2025: revenue was 2.88M (YoY +159.17%), missed estimates; EPS was -0.12 (YoY +60.00%), beat estimates.
Revenue / YoY
2.88M
+159.17%
EPS / YoY
-0.12
+60.00%
Report date
Aug 13, 2025
EPS
Actual | -3.57 | -0.52 | -0.25 | -0.35 | -0.35 | -0.25 | -0.22 | 1.58 | -0.28 | -0.24 | 0.25 | -0.21 | -0.29 | -0.3 | -0.29 | -1.27 | -0.24 | -0.12 | ||
Forecast | -0.7125 | -0.3825 | -0.358 | -0.288 | -0.35 | -0.332 | -0.282 | 1.315 | -0.154 | -0.226 | -0.222 | -0.0525 | -0.11 | -0.255 | -0.2375 | -0.245 | -0.25 | -0.205 | ||
Surprise | 0.00% | 0.00% | -401.05% | -35.95% | +30.17% | -21.53% | 0.00% | +24.70% | +21.99% | +20.15% | -81.82% | -6.19% | +212.61% | -300.00% | -163.64% | -17.65% | -22.11% | -418.37% | +4.00% | +41.46% |
Revenue
Actual | -- | -- | 0 | 100.00K | 489.00K | 0 | 0 | 0 | 0 | 39.85M | 1.75M | 3.67M | 11.94M | 1.69M | 1.71M | 1.11M | 3.87M | 4.30M | 4.37M | 2.88M |
Forecast | -- | -- | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 29.45M | 2.95M | 2.43M | 3.03M | 5.36M | 5.34M | 2.45M | 2.28M | 3.40M | 3.10M | 4.05M |
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | +35.34% | -40.74% | +51.50% | +294.52% | -68.43% | -67.96% | -54.67% | +69.49% | +26.53% | +41.03% | -28.84% |
Earnings Call
You can ask Aime
What is the revenue and EPS growth rate for Opus Genetics year over year?Did Opus Genetics beat or miss consensus estimates last quarter?What is the market's earnings forecast for Opus Genetics next quarter?What were the key takeaways from Opus Genetics’s earnings call?What factors drove the changes in Opus Genetics's revenue and profit?What were the key takeaways from Opus Genetics's earnings call?What is Opus Genetics's gross profit margin?What is Opus Genetics's latest dividend and current dividend yield?
